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Abstract
Background: The growing burden of non-communicable diseases in middle-income countries demands models of
care that are appropriate to local contexts and acceptable to patients in order to be effective. We describe a multi-
method health system appraisal to inform the design of an intervention that will be used in a cluster randomized
controlled trial to improve hypertension control in Malaysia.
Methods: A health systems appraisal was undertaken in the capital, Kuala Lumpur, and poorer-resourced rural sites
in Peninsular Malaysia and Sabah. Building on two systematic reviews of barriers to hypertension control, a conceptual
framework was developed that guided analysis of survey data, documentary review and semi-structured interviews
with key informants, health professionals and patients. The analysis followed the patients as they move through the
health system, exploring the main modifiable system-level barriers to effective hypertension management, and seeking
to explain obstacles to improved access and health outcomes.
Results: The study highlighted the need for the proposed intervention to take account of how Malaysian patients seek
treatment in both the public and private sectors, and from western and various traditional practitioners, with many
patients choosing to seek care across different services. Patients typically choose private care if they can afford to, while
others attend heavily subsidised public clinics. Public hypertension clinics are often overwhelmed by numbers of
patients attending, so health workers have little time to engage effectively with patients. Treatment adherence is poor,
with a widespread belief, stemming from concepts of traditional medicine, that hypertension is a transient disturbance
rather than a permanent asymptomatic condition. Drug supplies can be erratic in rural areas. Hypertension awareness
and education material are limited, and what exist are poorly developed and ineffective.
Conclusion: Despite having a relatively well funded health system offering good access to care, Malaysia's health
system still has significant barriers to effective hypertension management.
Discussion: The study uncovered major patient-related barriers to the detection and control of hypertension which will
have an impact on the design and implementation of any hypertension intervention. Appropriate models of care must
take account of the patient modifiable health systems barriers if they are to have any realistic chance of success; these
findings are relevant to many countries seeking to effectively control hypertension despite resource constraints.
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Background
The importance of developing robust responses to the
growing burden of non-communicable disease (NCD)
has been highlighted by two recent events, the 2010 up-
date of the Global Burden of Disease demonstrating the
scale of the epidemiological transition to NCDs [1] and
the 2011 United Nations High-Level Meeting calling for
urgent action to tackle NCDs [2].
Cardiovascular diseases are the largest contributor to
the NCD burden worldwide, with hypertension among
the most important risk factors [3, 4]. Appropriate re-
sponses span public health measures to prevent the on-
set of disease and health care to tackle risk factors and
established disease.
The means to manage hypertension have been avail-
able for decades and are cost-effective, requiring no
more than a sphygmomanometer for diagnosis, one, or
more often a combination, of cheap and effective drugs
for treatment [4, 5], but also, and somewhat more diffi-
cult to achieve, a health system that can make them
available to those in need. The achievable health benefits
are large as exemplified by the rapid declines in stroke-
related mortality that have occurred in most high in-
come countries during the past four decades [6]. Yet
these gains have been elusive in many low and middle
income countries, with most hypertensive individuals
unaware of their risk and, even if they are aware, unable to
receive treatment or achieve blood pressure control [7].
Effectively addressing hypertension requires strategies
that are multifaceted, involving preventive actions and
improved control, while overcoming established structural
and institutional barriers. This can appear unachievable in
situations with scarce resources and competing priorities,
risking a sense of therapeutic nihilism [8]. Consequently,
there has been limited attention from researchers and
their funders to the potential to deliver a pragmatic re-
sponse to hypertension in low and middle income country
settings.
NCDs are rising rapidly in many low and middle
income countries (LMIC), and prevention and control
has potential to make large inroads. One such country is
Malaysia, an upper middle income country, where we
have studied the barriers to effective hypertension detec-
tion, treatment and control. Lessons learnt from Malaysia
can be applied to many other countries. In the 2011
National Health and Morbidity Survey conducted in
Malaysia, which included 28,000 subjects, 32.7 % of partic-
ipants, aged 18 and over, had hypertension (systolic
≥140 mmHg, and/or diastolic ≥90 mmHg or self-reported
on treatment), of whom only 39.1 % were aware of their
status [9]; this places Malaysia in the middle of the range
of countries in the Western Pacific region of WHO [10].
An earlier nationwide study of over 16,000 subjects, re-
ported in 2007, found 27.8 % of those aged over 15 had
hypertension. Only 34.6 % of the subjects with hyperten-
sion were aware of their hypertensive status, and 32.4 %
were taking antihypertensive medication. Amongst the
latter group, only 26.8 % had their blood pressure under
control [11]; thus overall only 9.3 % of those with hyper-
tension were controlled and, to the extent that the surveys
were comparable, this suggests that the situation may be
deteriorating.
In contrast, some facility-based studies have found
higher rates of control but they only include patients
who are aware of their condition and are able to receive
care, thereby suffering from selection bias. For example,
one study of nine clinics found that, overall, 59 % of
1260 patients with hypertension were controlled [12].
However, rates varied substantially among clinics from
23.1 to 74.2 %, also indicating the scope for improve-
ment using practices already in place in some settings
that can be replicated elsewhere.
The components of a comprehensive health system re-
sponse are largely agreed. They include diagnosis, appro-
priate lifestyle and pharmacological treatment, and
regular monitoring to achieve control. However, it is far
from obvious that models of care developed in Western
countries can simply be transplanted to Malaysia as they
may be dependent on availability of resources, healthcare
system design, cultural influences and other factors.
One extension of the international PURE (Prospective
Urban and Rural Epidemiology) study, which is now fol-
lowing up over 180,000 people aged 35 and over in 21
countries to track trends in cardiovascular disease and
its risk factors [13], is the HOPE-4 randomized con-
trolled trial. HOPE-4 seeks to design and evaluate an
intervention that will comprise fixed single pill fixed
dose cardiovascular combination therapy, coupled with
advice on self-management, administered by mid-level
non physician health workers. However, as with any
complex intervention, the implementation will need to
take account of the characteristics of the health systems,
population preferences and local context. This requires
knowledge of the barriers that are likely to arise and
how these can be countered.
In this paper we describe the use of a multi-method
health system assessment to understand the barriers and
facilitating factors for optimal hypertension management
(diagnosis, treatment and control) in Malaysia from a
patient perspective. This approach has been previously
used to assess health systems performance, whereby it
uses a specific condition (such as hypertension) as a
tracer that can explore the functioning of the diverse el-
ements of the health care system [14]. In this case we
use it to identify barriers to effective management that
must be addressed in designing an intervention to be
evaluated in a subsequent cluster randomized controlled
trial.
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Methods
Theoretical framework
The approach to health systems assessment is under-
pinned by a conceptual framework (Fig. 1) that draws
on the model of health systems proposed in the 2000
World Health Report [15]. Recognizing the criticism
that the building blocks approach is somewhat mechan-
istic evaluating each block separately [16], the study
framework is modified to enable an analysis of the rela-
tionship between the various resources and components
of a health system (Fig. 1). It is informed by the “systems
thinking” approach [17] that addresses the complexity
of the health system and the interactions of sub-systems
leading to changes in the whole. The approach seeks to
explain the causes for certain phenomena, and to iden-
tify plausible pathways about how resource inputs
translate into outcomes. It draws on realistic evaluation
[18], in which “mechanism + context = outcome” and
where the focus is more on what intervention or policy
works in what circumstances. What “works” is assessed
from the perspective of the patients and frontline pro-
viders, as the ultimate beneficiaries of a well-functioning
system.
This multi-method approach is suited to many other
complex chronic diseases and has most often been used
with diabetes [19–21]. It recognizes that adequate health
care funding is necessary but not sufficient for optimal
health outcomes, which require the effective manage-
ment of four types of resources: physical, such as health
facilities, medical equipment, and drugs; human, such as
trained health workers; intellectual, such as evidence-
based guidelines and understanding by patients of the
nature of the disease and its management; and social,
such as means for patients to afford and access neces-
sary treatment. The framework also takes into account
the broader societal context and the overarching roles of
governance and finance in determining how the different
inputs are transformed into outcomes.
Document review and synthesis
The first step involved review and synthesis of official sta-
tistics, published and grey literature, survey data and gov-
ernment reports to understand the formal health system
and how it is expected to work. This involved searches
around key framework domains using Google and
PubMed, using the terms Malaysia and hypertension and
its synonyms, a search of Malaysian government and the
World Health Organization websites, documents identi-
fied by key informants, and a follow up of references cited.
Community sampling
This was used to frame the primary research which
sought to understand what happens in practice. Study
sites were selected from among those participating in
the PURE study [22] to cover diverse settings within
Malaysia: two urban sites close to the capital, Kuala
Lumpur (Petaling Bahagia and Sungai Buloh) and two
rural sites, one in Peninsular Malaysia (Tanjung Sepat)
and one in rural Sabah (Kota Marudu). The sites were
chosen on the basis of significant variations in hyperten-
sion prevalence and control, with marked differences
not only between urban and rural sites, but also within
each type of setting (Table 1). This approach made it
possible to capture a diversity of setting-specific barriers.
Field work was undertaken by local researchers, most
already working on the PURE project, who received train-
ing in health systems appraisal at a workshop held in
Kuala Lumpur, using a detailed manual developed for
hypertension that contained definitions, sampling frame-
works, and assessment tools, seeking to improve con-
sistency across sites. At each site, researchers identified
the main public health facilities at which people seek
Fig. 1 Conceptual framework of health systems assessment
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treatment for hypertension, and then identified private
and traditional providers serving the community.
Fieldwork and data analysis
Semi-structured interviews were conducted with a pur-
posive sample of patients with hypertension and health
professionals involved in hypertension management
(Table 2). Each clinic was visited over the course of a
few days. Attendance lists were used as a sampling
frame, from which patients being treated for hyperten-
sion were selected purposively, with the intention of
obtaining a mix of subjects by gender, ethnicity, and
hypertension control. Inevitably, those included reflected
the population served. Thus, all interviewees from indi-
genous groups were recruited in the community in
Sabah. The interview guides drew on earlier research in-
volving the authors on barriers to diabetes management
[19–21] and two systematic reviews conducted to iden-
tify health system and service barriers to hypertension
control [23, 24]. A convenience sample was used for
health professionals, but based on a pre-specified list of
those who would have direct patient contact as set out
in the study protocol. The interviews, which typically
lasted 30 minutes, explored patient pathways (from
initial diagnosis to consistent treatment), access to
medicines, adherence to treatment, and management of
complications. Key informants at national level were
identified through documentary analysis and were inter-
views, including civil servants and representatives of
professional organizations, to gain insights into the
hypertension-related regulation and policy context. The
source of each quotation cited is indicated as key in-
formant (KI), healthcare provider (HP) and patient (PA).
Ethical approval was granted by the respective com-
mittees at the Universiti Teknologi MARA and the
London School of Hygiene and Tropical Medicine. Fol-
lowing informed consent, interviews were conducted in
Bahasa Malaysia or English and recorded. Transcripts
were coded inductively using NVivo software eliciting
major themes and these were then mapped onto the
conceptual framework, constructing a narrative summary.
Findings and inferences emerging from the interviews
Table 1 Hypertension data from study sites in subjects aged 35–70 (2013)
Community name N Location Diabetes mellitus
prevalence
Hypertension
prevalence
Of which aware Of which treated Of which controlled
Petaling Bahagia 34 Urban 5.9 % 38.2 % 53.8 % 53.8 % 38.5 %
Shah Alam 133 Urban 10.5 % 45.9 % 58.9 % 58.9 % 17.6 %
Tanjong Sepat 127 Rural 7.9 % 57.5 % 46.6 % 32.9 % 9.6 %
Kota Marudu 334 Rural 3.9 % 47.6 % 59.1 % 48.4 % 23.9 %
Table 2 Characteristics of respondents by site
Petaling Bahagia
(urban, KL)
Tanjung Sepat
(rural, peninsula)
Marudu
(rural Sabah island)
UiTM
(urban, KL)
Total
M F M F M F M F
Type of Informant Key Informant 12
Health professional Public 0 3 1 3 2 3 0 1 13
Private 2 1 0 0 0 0 0 3 6
TCM 2 0 2 0 0 0 0 1 5
Total 8 6 5 5 24
Patient Public 2 4 0 2 3 8 6 4 29
Private 1 0 1 1 0 0 1 1 5
TCM 0 0 1 0 0 0 0 2 3
Total 7 5 11 14 37
Patient demographics Hypertension status Controlled 3 4 1 3 1 3 7 5 27
Uncontrolled 0 0 1 0 2 5 0 2 10
Ethnicity Malay 1 3 2 3 0 0 7 5 21
Indian 1 0 0 0 0 0 0 1 2
Chinese 1 1 0 0 0 0 0 1 3
Other minority 0 0 0 0 3 8 0 0 11
Total 15 11 16 19 73
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were triangulated with routine statistics, policy docu-
ments, published and unpublished literature throughout
all stages of the study and data interpretation [25].
Results
This section reports thematically the barriers and facili-
tators to effective hypertension management according
to the conceptual framework beginning with a descrip-
tion of the management of hypertension. Findings are
interpreted in the context of the Malaysian health sys-
tem (Appendix Tables 4 and 5).
The patient pathway
In theory, the patient should follow a standardized path-
way [26], with guidelines developed jointly by the Minis-
try of Health, Malaysian Society of Hypertension, and
Academy of Medicine of Malaysia [27]. The guidelines
envisage that all clinics should manage patients with
hypertension, with staff undergoing specific training in
screening and hypertension management. Fig. 2 illustrates
the barriers to effective hypertension care along the
patient pathway.
Screening and diagnosis
Most patients with hypertension reported being diag-
nosed after presenting to a clinic with symptoms, al-
though none of those interviewed suspected that their
symptoms might indicate hypertension. Blood pressure is
not routinely checked during attendance at primary care
clinics for other problems, contrary to national guidelines;
however some doctors do measure BP in all patients visit-
ing the clinics. Some clinics also have “self-checking
Fig. 2 Barriers along hypertension patient pathway
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corners” with a digital sphygmomanometer, to “encourage
or empower the public to look after themselves” (KI) al-
though there are no data on their utilization. Very few
asymptomatic patients ask for their BP to be checked,
with one Medical Officer noting: “Rarely people came in
just to have their BP checked [without symptoms], because
they think they are still young so why they need to have a
health check-up?”
Mass screening does, however, occur regularly, both at
work and in health promotion sessions (typically com-
bined with blood donation) known as “Family Days”,
undertaken by some clinics in the local community, usu-
ally in markets or outside mosques. One physician in an
urban clinic reported that “we usually detect 30 % asymp-
tomatic undiagnosed hypertension during our health cam-
paigns”. However, few of those identified with elevated
blood pressure return for confirmation of the diagnosis
even though they appear concerned about the initial
reading.
Follow-up
The guidelines recommend that those with controlled
hypertension receive check-ups every 4–6 weeks until
they are controlled and then every 3–6 months. Patients
report that this largely happens. In the public sector, a
nurse will take the patient’s blood pressure readings and
any other tests required, which are then followed up by
the Medical Officer as the nurse is not allowed to pre-
scribe. Commonly the Medical Officer will just “tell the
patient to continue medication, sometimes without phys-
ical examination” (HP); they report having little time to
talk with patients, and they simply “take their [the pa-
tient’s] word” as to whether they are adhering to medica-
tion and modifying their lifestyle as the doctors have
insufficient time to engage with them to ensure a shared
understanding. If a patient’s blood pressure continues to
be uncontrolled or they have complications, the Medical
Officer will refer them to a Family Medical Specialist
(FMS), a physician with advanced training in primary
care, for further investigation and management. Physi-
cians in the public sector reported how some clinics
struggle to cope with their workload. Some clinics offer
dedicated sessions for hypertension and its complica-
tions on specified days of the week, designed to allow
more time for detailed assessments and patient educa-
tion. However, physicians reported seeing 10 or more
patients per hour, or 100 in a day, leaving inadequate
time for meaningful interaction: “Many of healthcare
providers [are] not able to sit down and have counselling
session regarding their medications with their patients”
(KI). Other informants speculated that pharmacists and
nutritionists could also play a larger role in patient care
although they are not always present in facilities. Patients
face substantial waiting times. At one clinic only half those
scheduled to attend actually did, most of whom had an-
other condition, such as diabetes. In the private sector the
physicians will spend more time not only taking the pa-
tient’s blood pressure but advising on medication and
lifestyles.
Non-adherence to treatment
Health professionals identified non-attendance at clinics
and non-adherence to medication as a major problem.
Transport is important; official data state that 77 % of
the population live within 5 km of clinic, and 10–15 %
live more than 9 km away from a public or private facil-
ity, respectively (Fig. 3) [28]. However, in rural areas,
17 % of the population lives more than 9 km from the
nearest public clinic, and 40 % lives as far from a private
clinic. In our study, patients in rural sites in both penin-
sular Malaysia and Sabah identified a lack of affordable
transport as a critical barrier to attendance. In Sabah es-
pecially, individuals described travelling for up to a day
to reach a clinic, walking through jungle and crossing
rivers. Many elderly patients rely on their children for
transport. In urban areas, patients found difficulty in
taking time off work to attend the clinic: “Some of the
private companies don’t accept ‘time-off ’, but we [doctors]
cannot provide medical leave because [patients] were
only here for a few hours” (HP). Another factor, noted in
many settings, is that “from a patient perspective, hyper-
tension is often a silent disease and patients may not
take antihypertensive medications as directed because
their positive effects are not as obvious as potential side
effects from the medications” [29]. Interruptions in treat-
ment and drop out were commonly reported; patients
stop coming when their BP is under control, to return
months later with dangerously high BPs. However, a
commonly held view among providers and patients is
that many people are in denial about their condition, or,
having failed to follow the lifestyle advice given by physi-
cians on diet and exercise, were reluctant to see their
doctor. Some providers felt non-adherence is a problem
among patients of lower educational status as they be-
lieve “medicine equals money loss” (HP) whilst the better
educated are more adherent so that they remain healthy
to work, although they could provide no statistical evi-
dence to support these claims.
A third factor related to the widespread belief that life-
style modifications were difficult to reconcile with a
Malaysian diet high in oil, salt and sugary foods. Key in-
formants were concerned about the affordability of a
healthy diet: “The foods in Malaysia are cheap and var-
ieties which lead to hypertension… lifestyle, stress and
workload makes us not active, caused by [the] develop-
ment of [the] country” (KI).
Finally, there is no formal process for following up
non-attendees in any of the clinics. Although some
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clinics hold medical records that make this possible, in
most clinics patients keep their own records; clinics only
become aware of them when they return suffering from
complications. The situation is further complicated by
patients moving between public and private clinics. A
Malaysian information technology system, ‘Tele-Primary
Care’, has been implemented in some states, most exten-
sively in Sarawak, that should alert clinic staff when
patients are due for their next review and what investi-
gations they require, while informing decisions on their
medication. However, it has not been evaluated and nor
is it being rolled out nationally.
Where are patients looked after?
Despite an extensive, heavily subsidised public health
care sector, there is a strong and growing private health
sector, funded through out-of-pocket payments or com-
pany insurance. The public and private facility users dif-
fer. Private clinics reported that most of their patients
are insured by their employers and that they tended to
adhere to their medication “especially if in the compan-
ies’ policy does state that ‘you have to be fit to work with
us’” (HP). Company insurance often allows patients to
choose from a number of private clinics, which may
disrupt continuity of care (PA).
Those choosing to pay for private care were seeking
what was perceived as better quality, with shorter wait-
ing lists and better access to specialists: “If you had
hypertension and heart problems, you will get to see the
cardiologists [in a private hospital]; at public hospital
you will not necessarily be seen by cardiologist although
it’s a cardiology clinic, sometimes only the medical officer
in-charge” (HP).
Other studies in Malaysia have identified “the choices
of medications, the cost to the patients, doctors’ workload,
patients’ socioeconomic profile, practice infrastructure,
and support facilities” as playing a role [30]. Yet one
doctor argued that “in terms of diagnosis, full length of
investigation, government hospitals are better because we
have a strict protocol” (HP), although this was not sup-
ported by the evidence of frequent departures from
guidelines. Key informants reported that there is move-
ment between public and private sectors; users with
mid-level incomes might use private care for acute
Fig. 3 Distance from clinics in Malaysian states
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illness but move to the public sector care if they develop
a chronic condition, require in-patient care or are no
longer covered by insurance. Consequently, the public
sector was left with the most complicated cases, tending
to overwhelm it with patients with advanced disease.
However, some of those without insurance and unable
to afford private care may still avoid the overcrowded
public sector and self medicate or use Traditional and
Complementary Medicine (TCM) instead (KI).
Traditional and complementary medicine
Use of TCM in Malaysia is believed to be widespread,
with “a significant but unknown proportion of the popu-
lation consult unregistered traditional medicine practi-
tioners” [31], although many move between western and
traditional systems with the same conditions. A study of
the use of TCM for chronic disease management in Ipoh
found that “although 60 % on TCM subjectively felt im-
provement in BP control, this was not reflected in the
actual BP measurement obtained from the medical re-
cords” [32].
Health expenditure data from the Ministry of Health
report that 13 % of out-of-pocket expenditures are to
TCM providers [27]. A few TCM services, such as
Ayurvedic medicine and homeopathy, are provided by
the Ministry of Health but most patients pay out-of-
pocket for private TCM services and medicines.
Observations and interviews suggested that Ayurvedic
practitioners diagnosed hypertension using a sphygmo-
manometer while those from other traditions diagnosed
it on the basis of symptom reports or in patients report-
ing having been diagnosed by another doctor. There was
a divergence of views about the simultaneous use of
traditional and western treatments. Whilst it seems ac-
ceptable for Ayurvedic medicine to be used alongside
western medicine, a Malay traditional medicine practi-
tioner recommended that western medicines should be
discontinued when taking herbs. Many patients who re-
port regular use of western medicines for hypertension
also mentioned supplemental use of herbal remedies,
mainly to relieve perceived side effects of the western
medicines. Ayurvedic practitioners also encouraged
lifestyle modifications as well as medication, whilst
other TCM practitioners focused more on medications.
Ayurvedic practitioners were more likely to use regis-
tered herbal medications compared with other TCM
practitioners.
All three traditional belief systems (Traditional Chinese,
Ayurvedic, and Malay) see illness as largely time-limited,
reflecting imbalances between factors acting on the body
(Appendix Table 6). Consequently, it is difficult to accept
life-long treatment for a condition that is asymptomatic,
with many TCM practitioners arguing that they can cure
hypertension. This view contradicts the need for long-
term adherence to medication. One key informant noted
that “more than 50 % do not take their medication regu-
larly. [There are] myths about medication especially
among Malays, [that] medication will cause renal failure”.
This concern was common among patients interviewed,
believing that long-term daily consumption of any western
medication would cause damage to the kidneys, unlike
TCM drugs that are “natural”. Furthermore some western
drugs may not be considered halal, whilst most TCM are
considered so, with obvious consequences in a predomin-
antly Muslim majority state.
It was difficult to assess whether advice by alternative
practitioners to discontinue western medicines reflected
their belief system of illness as a temporary phenomenon
or because western medicines were in competition with
their products, and thus their income. Some patients in
Sabah favoured alternative medication as it was not ne-
cessary to follow a strict regimen; others started taking it
when they felt that western medication was not working
or if they experienced side effects. TCM is seemingly
popular with newly diagnosed hypertensive patients,
with many “asking around to get suggestion from their
circles to try TCM, mostly herbs” (HP). Patients will
rarely disclose to a medical doctor if they are taking
TCM supplements unless complications arise.
In practice, all of these factors seem to play a part in
low levels of adherence, especially when combined with
long waiting times and the prospect of taking the medi-
cation for life.
Physical resources
There are significant variations in access to equipment
and drugs. The facility checklists showed that while
health workers in urban clinics reported having no diffi-
culties, those in rural clinics had inadequate equipment
of all types, both in terms of supply and quality, with
much being very old. Urban clinics reported advising
many patients to purchase their own automatic sphyg-
momanometers, which was not possible in poor rural
areas. In the rural sites it was difficult to obtain labora-
tory results, with samples having to be transported con-
siderable distances.
Key informants at national level reported no problem
with access to medicines, contradicting the findings of a
2004 survey reporting widespread non-availability of
common medicines [33]. In our study, physicians at
urban sites reported few if any problems with access to
antihypertensive drugs, whilst those in rural areas re-
ported frequent stock-outs. Although doctors typically
prescribed a 3 month supply of drugs, public sector
pharmacists typically dispensed it in 1 month or even
2 week instalments to safeguard limited stock (HP), al-
though others said this was to encourage patients to re-
turn for regular check-ups.
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In the public sector, generic medicines on the national
formulary are supplied free to both in- and outpatients.
In the private sector, medicine is paid for out-of-pocket,
often providing brand-name drugs at higher prices [33].
Patients can purchase anti-hypertensive drugs at any
pharmacy with a prescription. Private sector clinics often
give 1 month prescriptions so as not to burden their cli-
ents financially. None of the patients interviewed re-
ported being unable to access drugs from a public clinic
or pharmacy, although some reported going without
medication when their prescriptions ran out and they
did not have time to obtain more.
Malaysia has, however, a large domestic pharmaceut-
ical manufacturing sector, with “80 % of drugs being lo-
cally manufactured” (KI), enabling some cost savings in
recent years.
Human resources
The Malaysian health workforce faces shortages of health
workers, with 0.9 physicians per 1000 population, which is
below the 2.2 per 1000 average in upper middle income-
countries. Although the public sector is well resourced,
only 7 % of doctors work in primary health care. While
the FMS, with their additional skills in family medicine,
can provide additional support, in 2008 there were only
149 in the whole country [34]. Our study indicates more
pronounced shortages in rural areas, with rural physicians
described feeling severely overworked due to staff short-
ages. The rarity of visits by FMS was also regarded by staff
and patients as contributing to long waiting times. The
Ministry of Health determines staff allocation according
to clinic catchment areas, so some will be allocated a full-
time FMS, whilst others with fewer than 250 patients per
day will receive only intermittent visits from a FMS, with
most care provided by Medical Officers with basic
training.
Continuity of care was of concern at all public sector
sites, with patients seeing a different doctor each time they
attend the clinic. This posed a problem given the signifi-
cant variations in hypertension management. This is exac-
erbated by the high turnover of physicians and medical
assistants in many areas, with the Ministry of Health offer-
ing only short contracts and arranging frequent redeploy-
ments in rural areas. Undergraduate medical training does
not focus on primary care, so that newly qualified doctors
are often unfamiliar with the conditions seen at this level.
Some clinics did, however, describe implementing ap-
pointment booking systems so that Medical Officers can
see the same patients and thus maintain continuity of
care. Both doctors and patients regarded this as import-
ant in building trust and rapport, with benefits for ad-
herence to treatment.
The involvement of other health professionals is an area
where rhetoric departs from reality, as key informants
described the involvement of dieticians and nutritionists
in hypertension management, supporting patients with
lifestyle modifications, but these cadres were not found in
any of the clinics observed. Furthermore, at all sites,
health professionals reported a language barrier between
Malay staff and Chinese and Indian patients, making com-
munication difficult; this was further complicated given
the indigenous languages in rural Sabah.
Intellectual resources
Guidelines
As noted above, clinical guidelines for management of
hypertension exist and are widely disseminated. Devel-
opment of Clinical Practice Guidelines (CPGs) is under-
taken by working groups under the auspices of the
Ministry of Health, and revised every 5 years to account
for newly emerging evidence. The CPGs are published in
various formats for health professionals in work and in
training, and for patients, and appear on the Ministry of
Health website. All health professionals interviewed re-
ported using them, albeit tempered by their clinical
judgment, finding them straightforward and clear. Some
health professionals, however reported being too “over-
whelmed with patients to follow everything inside the
CPG” (KI). Given the evidence that guideline adherence
improves hypertension control [35] this could have im-
plications for quality of care. There was also concern
that guidelines for different conditions were sometimes
inconsistent. Private clinics are even less regulated and do
not have “SOP [standard operating procedure] for their
medical officers; it’s up to the individual judgment” (HP).
Patient awareness of hypertension
There was widespread concern among health profes-
sionals about a poor understanding of hypertension and,
specifically, the need to maintain treatment when asymp-
tomatic, as noted above. Educational materials produced
by the Ministry of Health came in for particular criticism
from health professionals. These were developed with lit-
tle input from target audiences such as patients. They took
no account of the deeply entrenched health beliefs, were
considered to have little impact on raising awareness of
hypertension or its risk factors, and were characterized by
paternalistic messages delivered through a top-down ap-
proach. One key informant reported that the education
materials were: “Not effective at all, we are not getting the
message across…I think the education materials that we
have now are not dynamic, not customized. It’s too
general”.
Few patients reported receiving any leaflets or other
materials from the clinics. Little printed information was
visible in any of the clinics, and what was in them was
outdated and poor quality. In Tanjung Sepat, however,
health professionals had developed their own
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hypertension information pamphlets but none were
found in the clinics; a nurse explained that parents
would often give them to children in the waiting area to
play with and they had not been replaced. The materials
are produced by Ministry of Health so clinics must re-
quest them from the Ministry, and these are therefore
often lacking in the clinic sites. As a consequence,
patients reported that the information they did obtain
was mainly from the media and other community mem-
bers; many cited television advertisements by the Minis-
try of Health. The increased use of the internet has not
necessarily promoted access to evidence-based informa-
tion. There was particular concern that the mass media
was redolent with advertisements for unhealthy products,
such as certain foods and products or health supplements,
as well as advertisements for ‘wonder-drugs’.
Social resources
Most patients reported having been offered counselling
on how to manage their hypertension by their physi-
cians. The Ministry of Health is “specifically looking at
patient support group or peer support groups” (KI), but
other informants reported that the “ministry have failed
to empower other agencies to [be involved/volunteer in
hypertension programmes] because the ministry is think-
ing that we are the better person with this”. A peer sup-
port group had been established in the Tanjung Sepat
clinic but one health professional there noted: “Peer sup-
port groups… I find it still lacking in Malaysia… maybe
because of our setup our cultural belief that not many
patients are willing to actually share their experience”.
There is also a Hypertension Club in Kuala Lumpur
that allows patients to exchange information, although
no patients interviewed had attended this. There are no
specific state benefits for people suffering from NCDs.
The national strategy on NCDs [36] proposes support
for health promoting initiatives, such as those in schools,
although some key informants considered that these
lacked popular support and had achieved limited suc-
cess. There is limited social support for patients: the
strategy requires that health clinics be linked to the So-
cial Welfare Agency, to support patients who need spe-
cific support or home-visits, but patients reported that
applications for support take a long time.
Discussion
Innovations in health care delivery are frequently imple-
mented without any attempt to evaluate them and assess
the extent to which they respond to patient needs. Even
when they are subject to an evaluation, it is rare for
them to be tailored to the local context [37]. This is in
marked contrast to the development of medicines,
where vast sums are spent to develop and refine the
product, in terms of dosage, presentation, and mode of
administration before it ever gets near a patient. One re-
view of malaria programmes concluded that many “fail
to utilize findings from social science research and as a
result, achieve minimal results” [38].
This study has provided valuable insights into the
management of hypertension in Malaysia. It finds that,
while NCDs are now high on the political agenda, the
focus is predominantly on diabetes, with rather less atten-
tion to other conditions such as hypertension. Patients
with hypertension are diagnosed when they present with
symptoms, which may or may not relate to their hyperten-
sion but this suggests that many may be diagnosed at a
relatively late stage. Mass screening activities take place
but, although not subject to formal evaluation, seem to be
of limited value as few people in whom elevated blood
pressure is detected are followed up. Once commenced
on treatment, arrangements are made for routine follow
up but attendance is low, largely because of a combination
of travel times (rural areas), difficulty taking time off work
(urban areas), and long waits in clinics. The problems are
greatest in rural areas, which face shortages of basic
equipment and medicines, with shortages of physicians
who change regularly, making continuity of care difficult.
In more remote areas where many patients are from indi-
genous groups there may also be language barriers. How-
ever, even in urban areas, many of those who can (mostly
those with insurance cover), seek private care. Guidelines
exist and are generally viewed positively, although some
are contradictory and there may be insufficient time to ad-
here to them in detail. Patient adherence to treatment
seems low and, at least in part, this seems to reflect trad-
itional beliefs, from different sources, that view disease as
a transient imbalance that, once corrected, does not re-
quire continuing treatment. Linked to this, it is apparent
that many people seek traditional remedies, in combin-
ation with or instead of recommended evidence-based
treatments. Notwithstanding these concerns, there does
seem to have been some progress since a 2007 evaluation
of hypertension services [39].
A recent study undertaken in a tribal area of India
echoed our findings in Malaysia, such as reliance on trad-
itional medicine, non-adherence to medication, inappro-
priate education materials, and logistic challenges in
accessing care [40]. Even though that study was under-
taken in a completely different setting, its findings are re-
markably similar to ours, indicating a broader relevance.
Before discussing the implications for design of an inter-
vention, it is necessary to reflect briefly on the strengths
and limitations of this innovative approach to appraise the
health system. Its main advantage is that it takes user per-
spective and identifies upstream bottlenecks at local, dis-
trict and national level, drawing on theories and
frameworks for analysing health systems operations. It
uses a range of qualitative and quantitative methods in an
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iterative and reflexive approach allowing for collection
and analysis of data that is rigorous yet pragmatic. Yet
whilst a wide range of stakeholders were enrolled in
this study, the sampling methodology created an inevit-
able bias towards those patients who attend health
clinics, as well as towards providers and key informants
who were willing to provide information, which tended
to emphasise the role of the public sector. There was
also a bias towards the Malay population due to lan-
guage spoken by the researchers. However, we did tri-
angulate our findings with different sources, including
existing literature. Thus, as in an earlier study, we
found that patients most likely to access hypertension
care in the public sector are older, female and of Malay
ethnicity [30].
Our findings have been very important in designing
an intervention that will now be evaluated as a poten-
tial means of improved hypertension management.
Table 3 demonstrates the various barriers to effective
hypertension management within and outside the
health system in Malaysia, and at different levels that
must be tackled in the design of an intervention. The
most important barriers relate to the management and
clinical practice within clinics and health beliefs. Both
have implications for adherence to treatment, although
it is important to note that poor adherence is a virtu-
ally universal problem, even if the precise causes vary
[41–43]. We found little evidence for any major finan-
cial barriers to accessing care or medication, since pub-
lic sector care is heavily subsidized and medication is
widely available in the public and private sectors. How-
ever the rapid staff turnover and long waiting times are
a matter of concern. Additionally, the intervention will
need to tackle particular problems in rural areas, and
among different population, ethnic and socio-economic
groups. This is a very different situation from that in
Colombia, where this study is also being undertaken,
where shortages of drugs are widespread everywhere
[44]. Nor are there major concerns about financial bar-
riers, with out-of-pocket payments only being paid by
those opting for private care, most of whom are at
least partially covered by occupational health insurance.
We did not find evidence of informal payments, unlike
the situation in many other middle income countries.
Most clinics reported having adequate diagnostic equip-
ment, even if not always the most modern, but there were
significant managerial problems.
This analysis shows how, in Malaysia, an intervention
must include messages that take full account of deeply
held beliefs that do not recognize long term asymptom-
atic conditions and lead many patients to use traditional
medicines that may conflict with western approaches to
management. There is growing recognition of the need
to understand health beliefs in influencing medication
adherence, with a recent systematic review showing
both similarities in many diverse settings worldwide but
also some cultural specificities [45]. This paper adds to
that literature which, so far, has provided evidence
mainly from high income countries. As elsewhere, there
is much scope to increase understanding of hyperten-
sion among both patients and health professionals, with
evidence from other settings that patient empowerment
and education can improve health outcomes in hyper-
tensive patients [46] when done well. However there is
a need to test messages related to the risks of hyperten-
sion and the need for long-term treatment even when
asymptomatic. This requires skills in cognitive psych-
ology and market research. There is now considerable
experience with social marketing in some areas of
health promotion, for example, for reproductive health
[47], but less so in relation to cardiovascular disease.
However, where it has been tried, it has led to innova-
tive methods, such as the use of community workers or
house parties to raise awareness [48]. It is, however, im-
portant that these approaches do not become simply
tokenistic in their efforts to address cultural diversity
[49]. It is also important that the messages emerging
should be sustained and consistent throughout the
health system, which will require harmonization of
guidelines and training for health workers to work to-
wards the same goals [50].
The analysis also identifies the high opportunity cost
to patients imposed by transport problems and the time
required to obtain care. The former is difficult to tackle
by actions within the health system but both may be al-
leviated to some extent by extending clinic hours. Given
the costs that arise in these ways, there may also be a
case for considering conditional cash transfers as incen-
tives to attend regular follow up. These have been
shown to be effective in relation to other aspects of
health care [51], but there are considerable financial and
governance challenges.
There is also a clear need to improve detection and
treatment of hypertension. Ideally, every patient over a
certain age would have their blood pressure measured at
every encounter with a health worker. However, this will
not be easy (or indeed possible) with the staffing levels
available. Even for patients who have had treatment ini-
tiated, staffing levels are inadequate, reflecting a national
shortage of physicians and maldistribution, with very
few working in primary care, especially in rural areas,
where those that do exist are employed on short-term
contracts or are frequently redeployed. Malaysia also has
a low density of nurses compared to its neighbours, al-
though the situation is complicated because it is both a
major importer and exporter of nursing staff [52]. This
points to the need for task-shifting, and for more of the
workload to be undertaken by mid-level non-physician
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Table 3 Barriers to hypertension control in Malaysia
Community and household level Health service delivery level Health sector policy and governance level Environmental and contextual characteristics
Hypertension clinical
management
- Health beliefs leading to non-adherence
to drugs
- Lack of routine screening - Lack of effective public awareness
campaigns
- Lack of understanding of access issues
from a patient perspective
- Supplementary use of traditional therapies,
sometimes leading to discontinuation of
Western medication
- Lack of follow-up from community
outreach activities
- Lack of incentives for health staff or
clinics to improve quality of
management or care
- Weak response to risk factors for
hypertension, such as food industry
regulation
- Patients seeking care across public, private
and TCM providers, disrupting continuity
of care
- Little time with patients for effective
counselling and management
- Lack of continuity of care between
and within public and private sector
- Lack of regulation of TCM
- Failure to dispense enough
medications to last between check-ups
- Lack of evidence for TCM
- Overburdened public health system
puts pressure on resources due to
private sector dumping
- Clinics are not open out of working
hours
External issues - Access to clinics due to transport or
working hours
- Lack of social support or counselling
available for hypertension patients
- Weak civil society
- High fat and oil diet is cheap
and accessible
- Lack of regulation of food and
tobacco industry
Source: Authors’ assessments, using a structure adapted from Hanson et al., [53]
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health workers. However, this must be accompanied by
enhanced training of those such as nurses, who could
assume new roles. This will also require an imaginative
response to the legal prohibition on cadres other than
doctors prescribing medication. One possibility might
be to allow nurses to vary dosages within protocols al-
though, in the longer term, legislative change will be
needed.
It will be important to consider new approaches, such
as those made possible by technological advances. For
example, non-physician health workers could screen pa-
tients using electronic sphygmomanometers, complete a
check list on a smart phone or tablet that would then
calculate cardiovascular risk scores (and stratify individ-
uals into high, medium and low risk), identify concomi-
tant risk factors that require modifications (e.g. smoking
or diabetes), key contraindications to specific drugs (e.g.
a beta-blocker if there is asthma) and recommend the
use of low dose single pill combination medicines, which
will reduce the number of “steps”, visits and drugs for
the health care provider and the patient and generate
specific “warnings” when the patient needs to be
referred “upwards” to a physician. Such a system can in-
crease adherence to clinical practice guidelines, provide
documentation and quality control, minimize costs, and
enhance the effectiveness of the non-physician health
worker. This approach can also provide answers to fre-
quently asked questions to enable the non-physician
health workers to dispel common myths and misunder-
standings about hypertension and is being piloted in the
next phase of the HOPE 4 study in both Malaysia and in
Colombia. However, in the longer term, there is also a
need to ensure that there are sufficient staff available
and that the country develops measures to increase
training and retention.
Conclusion
This appraisal of the Malaysian health system has re-
vealed how, despite a highly-subsidized and mostly easily
accessible public health system with good availability of
drugs, there are still significant barriers to effective
hypertension management. These lie mainly in a limited
popular awareness of hypertension as a chronic yet
manageable condition, competing health belief models, a
shortage of physicians, and poor management of avail-
able resources. Although these factors can be found in
many settings, an understanding of their specific nature
is important for the development of a contextually ap-
propriate intervention. Yet, too often, this step is miss-
ing in health systems research. Integrated and innovative
solutions are needed to manage patients using non-
physician health workers and, if successful, can over-
come many of the barriers to effective hypertension
control.
Appendices
Table 4 Key characteristics of the Malaysian health system
The Malaysian health system comprises a mix of public and private
funding and provision. The centrally organized public health sector
provides 82 % of inpatient care and 35 % of ambulatory care, with the rest
provided through the fast-growing private sector [31]. The public sector
comprises a large network of primary care clinics, each typically serving a
population of 20,000, staffed by a doctor (Medical Officer), pharmacist and
nursing staff and overseeing a number of nurse-staffed community clinics
providing maternal and child health. Doctors in public clinics are sup-
ported by Family Medicine Specialists (FMS), who visit regularly to advise
on patients with more complex conditions. Secondary care is provided in
five types of hospitals (defined in terms of size, specialization, and
whether specialists are resident or visit). There is no gate-keeping system,
with Ministry of Health having an “open door policy on outpatient ser-
vices and hospital admissions” [31], allow patients to choose where they
seek care. Public health services are administered centrally by the Ministry
of Health (Ministry of Health), although the Ministry of Higher Education
also runs university teaching hospitals, the Ministry of Defence has mili-
tary health services, and, in some remote areas, the Ministry of Aboriginal
Affairs provides services for indigenous populations.
As well as the formal medical system, there are also many traditional,
complementary and alternative medicine (TCM) practitioners drawing
on the beliefs of the three main communities: traditional Malay healers
(bomohs), Traditional Chinese Medicine practitioners, and Ayurvedic
practitioners serving the Tamil population.
Financing and insurance: Total health expenditure in 2011 was 4.26 % of
GDP, equivalent to US$422 per capita [54], which is low compared with
neighbouring SE Asian countries [55] and upper-middle income countries
overall. In 2011, 45 % of total health expenditure was from Ministry of
Health, with 37.7 % coming from out-of-pocket payments (OOP); OOP
payments account for 78 % of private sector funding. Private insurance
contributed only 7 % of Total Health Expenditure [54]; and Social Security
Organisations account for only 0.68 %. Public clinics receive a fixed annual
budget, linked to performance indicators and budget lines, with the rationale
of providing equitable levels of care across the country [31]. Primary care is
largely subsidized by Ministry of Health as part of their efforts towards
universal health care coverage, brought in in the 1980s. Attendances at
primary care clinics involve a small co-payment of RM1 (€0.25) for registration
and regular consultation, and RM5 (€1.25) for specialist consultations. With
the large subsidized public sector, there is no government social insurance
scheme. The private sector has expanded rapidly in recent years, primarily in
urban areas where investment in new public facilities has not kept pace with
population growth and where disposable incomes are higher. There is a
small private insurance market, primarily for expensive hospital treatment.
Table 5 NCDs in Malaysia
NCDs have been on the policy agenda for almost two decades after a
substantial rise in their prevalence was noted in the National Health and
Morbidity Survey II (NHMS II, 1996). In response, the National Diabetes
Prevention and Control Programme was launched in 1996 and
strengthened in 2000 [56]. It was the precursor of the National Strategic Plan
on Non-Communicable Diseases (NSP-NCD) 2010–2014, [36] which sets out
a comprehensive action plan for the major NCDs, setting a new direction.
This new political will was seen as having driven certain structural changes,
such as the establishment of an NCD section within the Disease Control
and the Family Health Development Divisions of the Ministry of Health,
with complementary actions in other ministries and greater engagement
by the Malaysian government with NCDs in the global arena. However,
there are also concerns that the Ministry of Health is still dominated by silo
working that hindered progress, with others expressing concern that the
government’s programmes remained focused on individual diseases. It
was suggested that this might be due to an unwillingness to confront
powerful vested interests in the food and tobacco industries.
A high priority has been given to diabetes, which has been supported
by a strong lobby since the 1990s. A 1996 Healthy Lifestyle campaign
on Diabetes is cited as an example of positive action [31].
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